🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This year’s medicine laureates Victor Ambros and Gary Ruvkun studied a relatively unassuming 1 mm long roundworm, C. elegans. Despite its small size, C. elegans possesses many specialised cell types such as nerve and muscle cells also found in larger, more complex animals,

The 2024 #NobelPrize laureates in chemistry Demis Hassabis and John Jumper have successfully utilised artificial intelligence to predict the structure of almost all known proteins. In 2020, Hassabis and Jumper presented an AI model called AlphaFold2. With its help, they have

Holla at your New Department of Medicine’s Vice Chair Laura Raffals, MD!! 🌟 In this role she will implement, lead and foster an environment where faculty and staff can thrive and advance the department's mission. #letsgo Mayo Clinic Gastroenterology & Hepatology #womeninmedicine #womeninGI #patientcare

Congrats to ⁦⁦Dr Susie Kane for becoming Master of the ACG! ⁦ACG⁩ ⁦Mayo Clinic Gastroenterology & Hepatology⁩ ⁦Jonathan Leighton, MD⁩

Impressive #ACG2024

#CGH4ALL 💭imagine living in a 🌎 w/ standardized objective definition of transmural healing in Crohn's disease (CD) 🔖Check out the newly developed MRI score🩻to assess therapeutic efficacy in CD in CGH 🎩 to the authors 🔗doi.org/10.1016/j.cgh.… Report Nishant Aggarwal, MD

📣Unete ahora al convo con Vicent Hernandez Aline Charabaty, MD, FACG, AGAF 🎯Manejo de la #EII con perspectiva internacional 🗳️#IBDPoll 👇🏽& 💬 Comparte tus pensamientos con nosotros 🆓#CME bit.ly/MNIBD24-25 Support by edu grants Takeda JanssenUS AbbVie

🌟 Our first-ever living guideline for managing moderate-to-severe #UlcerativeColitis led by Berkeley Limketkai, @manasiagrawalmd, @Jhaydek, @ashwinmdibd, Frank I Scott, MD MSCE, Edward Loftus prioritizes early use of advanced therapies over a step-up approach. ow.ly/t2Ru50UahEi

An evaluation of risankizumab for the treatment of moderate-to-severe ulcerative colitis: Expert Opinion on Biological Therapy Amanda Johnson, MD Taylor & Francis Creative Media and the Arts #IBD tandfonline.com/doi/full/10.10…

Post hoc analysis of the OASIS and ELEVATE UC trials shows non-serious adverse events (eg. headache, dizziness) were slightly more frequent with etrasimod vs placebo in UC patients, but all events were short-lived, reaffirming etrasimod's safety profile 🔗journals.sagepub.com/doi/epdf/10.11…

Undetected Dysplasia at Colectomy in Patients With Inflammatory Bowel Diseases. What Are We Missing? academic.oup.com/ibdjournal/art… IBDJournal & CC360 Nayantara Coelho David Larson, MD MBA Erica Centorrino #IBD #dysplasia

How long should we wait for response in Ulcerative Colitis? ⏰ Great summary slide by Millie Long ➡️Estimated time for each group ➡️Delayed response can happen!🔗 similar maintenance results as early responders #AIBD2024 @IBDConference Corey Siegel Miguel Regueiro

➡️ Dr. Siegel bringing awareness of the current state of IBD treatment - despite all new advanced therapies we have, remission is still difficult to achieve for patients w/ IBD Corey Siegel Maia Kayal MD #AIBD2024

Thank you Steve Hanauer for decades of leading the IBD world and educating us all Millie Long Miguel Regueiro

Congrats to Jordan Axelrad, MD, MPH and amazing clinician, scientist, colleague and friend on his Sherman Prize! All of us at Gastroenterology & Hepatology | NYU Langone Health NYU Langone Health are so proud of you and honored to work with you 🙌🚀 #AIBD2024 @IBDConference

2024 Sherman Prize winner Millie Long. One of the most inspiring, kind and accomplished doctor, wife, mother and researcher I know. So proud to call you friend. May the world bless us with more like you

I'm running the Chicago Marathon with Crohn's & Colitis Foundation Team Challenge to support those affected by Crohn's & Colitis. Join me in making a difference—every donation brings us closer to better treatments and a cure! 🏃‍♂️💙 Donate here: …challenge.crohnscolitisfoundation.org/index.cfm?fuse…

#CCCongress24 #IBD & Obesity Amanda Johnson, MD 📈20-50% of pts w #IBD are overweight or obese ⬆️ Risk of IBD complications ⬇️ Response to biologic, might need higher IFX level to achieve remission 💉GLP1 agonist ✔️Effective & safe in IBD ✔️May ⬇️ pro-inflam cytokine

The twitterless Singhmeister also involved!!! Reviews on costs of #IBD care, prediction/prevention, diet/microbiome-directed therapy, “the clinic of tomorrow”, A.I. in care/research/trials, culturally sensitive/inclusive care, positioning Rx, combination Rx, and future of RCTs!

OBESITY AND IBD by Edward Loftus Obesity is a chronic inflammatory statue Adipose tissue is not biologically inert (TNFa, IL-6, IL-8, leptin, adiponectin) Postulated role in the pathogenesis of IBD Potential risk factor for adverse outcomes Trends in BMI among IBD patients at